EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Noninvasive imaging biomarkers of chronic liver disease severity and prognosis

Yavuz B Taktak iD, Burak Gultekin, Muhammed Enes Tasci, Oyku Ikizgul iD, Halil Ertugrul Aktas, Andrea M Bejar, Kerem Arisin, Esin Ozkan, Irem Sena Bayrak, Ece Busra Elustu, Ayse Ece Taymez, Ibrahim H Akkis iD und 13 weitere

Abdominal Radiology · 16.11.2026

DOI: 10.1007/s00261-026-05866-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 16.11.2026. Verfasst von Yavuz B Taktak und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Istanbul University School of Medicine, Istanbul, Turkey. yavuztaktak@istanbul.edu.tr. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate whether MRI-derived functional and morphologic biomarkers are associated with clinical severity and prognosis in chronic liver disease (CLD). Materials and Methods In this retrospective single-center study, 165 adults with chronic liver disease (CLD) who underwent gadoxetic acid-enhanced MRI were included. Functional Liver Imaging Score (FLIS) was assessed on 20-min hepatobiliary-phase images, and Liver Surface Nodularity (LSN) was measured on contrast-enhanced axial T1-weighted images using semi-automated software. Spearman correlation analysis was performed for associations with Model for End-Stage Liver Disease 3.0 (MELD 3.0), and Albumin-Bilirubin score (ALBI). Time-to-event analyses for liver transplantation or death within 4 years were performed using Kaplan–Meier analysis and Cox proportional hazards models. Receiver operating characteristic (ROC) analysis was used to evaluate the performance of FLIS for predicting 1-year transplant-free survival (TFS).

Results

FLIS showed moderate inverse correlations with MELD 3.0 (ρ = − 0.532, p < 0.001) and ALBI score (ρ = − 0.541, p < 0.001). LSN showed weak positive correlations with MELD 3.0 (ρ = 0.154, p = 0.049) and ALBI score (ρ = 0.184, p = 0.018). In univariable Cox analysis, older age, lower FLIS, higher MELD 3.0, higher ALBI score, and LSN cutoff ≥ 3 were associated with a higher risk of liver transplantation/death. In multivariable analysis, age (hazard ratio (HR), 1.05; p < 0.001), MELD 3.0 (HR, 1.08; p = 0.003) and FLIS group (0–3 vs 4–6 points; HR, 2.39; p = 0.007) remained independently associated with liver transplantation or death. For 1-year TFS, FLIS with an optimal cutoff of ≤ 3 yielded an area under the curve (AUC) of 0.71 (95% confidence interval (CI), 0.61–0.82).

Conclusion

Our findings suggest that MRI-derived functional and morphologic biomarkers, particularly FLIS, may provide noninvasive imaging markers of disease severity and prognosis in patients with CLD. Prospective studies with long-term clinical outcomes are needed to define their role in risk stratification and transplant decision-making.

Schlagwörter

Stichwörter der Autor:innen

Chronic liver diseaseFunctional liver imaging scoreGadoxetic acid-enhanced MRILiver surface nodularityPrognosisTransplant-free survival

Autor:innen und Institutionen

  • Department of Radiology, Istanbul University School of Medicine, Istanbul, Turkey. yavuztaktak@istanbul.edu.tr.
  • Department of Internal Medicine, Uskudar State Hospital, Istanbul, Turkey.
  • Department of Radiology, Northwestern University, Chicago, United States.
  • Department of Radiology, Istanbul University School of Medicine, Istanbul, Turkey.
  • Department of Public Health, Marmara University School of Medicine, Istanbul, Turkey.
  • Department of Internal Medicine, Istanbul University School of Medicine, Istanbul, Turkey.

ORCID-Profile: Yavuz B Taktak, Oyku Ikizgul, Ibrahim H Akkis, Alpay Medetalibeyoglu, Daniela P Ladner, Gorkem Durak, Sukru Mehmet Erturk

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Taktak, Y. B., Gultekin, B., Tasci, M. E., Ikizgul, O., Aktas, H. E., Bejar, A. M., Arisin, K., Ozkan, E., Bayrak, I. S., Elustu, E. B., Taymez, A. E., Akkis, I. H., Yokus, C. D., Haghshomar, M., Sanal, D., Senkal, N., Keles, E., Medetalibeyoglu, A., Dagoglu Kartal, G., …, & Bagci, U. (2026). Noninvasive imaging biomarkers of chronic liver disease severity and prognosis. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05866-7

Vancouver

Taktak YB, Gultekin B, Tasci ME, Ikizgul O, Aktas HE, Bejar AM, et al. Noninvasive imaging biomarkers of chronic liver disease severity and prognosis. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05866-7

BibTeX
@article{Taktak2026,
  author = {Taktak, Yavuz B and Gultekin, Burak and Tasci, Muhammed Enes and Ikizgul, Oyku and Aktas, Halil Ertugrul and Bejar, Andrea M and Arisin, Kerem and Ozkan, Esin and Bayrak, Irem Sena and Elustu, Ece Busra and Taymez, Ayse Ece and Akkis, Ibrahim H and Yokus, Can Deniz and Haghshomar, Maryam and Sanal, Derin and Senkal, Naci and Keles, Elif and Medetalibeyoglu, Alpay and Dagoglu Kartal, Gulbiz and Borhani, Amir A and Ladner, Daniela P and Kaymakoglu, Sabahattin and Durak, Gorkem and Erturk, Sukru Mehmet and Bagci, Ulas},
  title = {Noninvasive imaging biomarkers of chronic liver disease severity and prognosis},
  journal = {Abdominal Radiology},
  year = {2026},
  doi = {10.1007/s00261-026-05866-7}
}
Kostenlos starten →